Management of Peripheral Vein Thrombophlebitis

Diagnosis and Classification

Thrombophlebitis can be classified as superficial or deep, with different management approaches required for each type 1
Diagnosis is primarily clinical, with signs including pain, erythema, induration, and palpable cord along the affected vein 2
Ultrasound assessment should be performed to rule out extension into the deep venous system, which would change management 3
Patients should be assessed for risk factors for extension, including proximity to deep veins and presence of ongoing risk factors 1

For patients with peripheral vein thrombophlebitis, treatment should include immediate anticoagulation with fondaparinux 2.5 mg daily for 45 days or rivaroxaban 10 mg daily if parenteral therapy is not feasible, along with compression therapy and catheter removal if present 1
For isolated superficial thrombophlebitis at increased risk of clot progression, fondaparinux 2.5 mg daily for 45 days is recommended over no anticoagulation 1
For patients unable or unwilling to use parenteral anticoagulation, rivaroxaban 10 mg daily is suggested 1

Immediate removal of the catheter is recommended for peripheral vein thrombophlebitis 4, 5
For catheter-related thrombophlebitis, surgical excision of the vein plays an important role in treatment of peripheral vein thrombophlebitis 6
Prevention strategies include using aseptic technique during catheter placement and care 5, using the smallest gauge catheter possible 5, using polyurethane or silicone catheters rather than Teflon 5, adequate fixation of the catheter with transparent adhesive membranes 5, and careful monitoring of infusion osmolarity and pH 5

Suppurative thrombophlebitis should be suspected in patients with persistent bacteremia or fungemia without another source 2
Management includes surgical resection of the involved vein, especially for purulent superficial veins 2, antimicrobial therapy for a minimum of 3-4 weeks 2, and diagnostic imaging to confirm thrombus presence 2
If thrombophlebitis extends into the deep venous system, treat as deep vein thrombosis 1, 7

Fondaparinux 2.5 mg daily for 45 days is the preferred option for superficial thrombophlebitis at risk of progression 1
Direct oral anticoagulants are preferred over vitamin K antagonists for deep extension cases due to better safety profile 7
Low molecular weight heparin options include enoxaparin 1 mg/kg twice daily or 1.5 mg/kg once daily 3, and dalteparin 200 U/kg once daily 3

Compression therapy should be started early and continued for at least one year 7
For patients with recurrent thrombophlebitis, evaluate for underlying conditions such as thrombophilia or malignancy 8

Failing to assess for extension into deep veins, which requires more aggressive treatment 1, 3
Delaying catheter removal in catheter-related thrombophlebitis 4, 5
Overlooking the importance of compression therapy in preventing complications 7